NDC Code(s) : 0069-0112-01
Packager : Pfizer Laboratories Div Pfizer Inc

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

RifampinRifampin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0069-0112
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
RIFAMPIN(UNII: VJT6J7R4TR)
(RIFAMPIN - UNII:VJT6J7R4TR) 		RIFAMPIN600 mg in 10 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM FORMALDEHYDE SULFOXYLATE(UNII: X4ZGP7K714)10 mg in 10 mL
SODIUM HYDROXIDE(UNII: 55X04QC32I)
Product Characteristics
Color RED (Red-Brown) Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0069-0112-011 in 1 CARTON
110 mL in 1 VIAL
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA065421 05/10/2011

PRINCIPAL DISPLAY PANEL

NDC 0069-0112-01

1 Vial

Rifampin for
Injection, USP
600 mg/vial

Sterile
For IV Infusion Only

Pfizer Injectables
 Rx only

Principal Display Panel - 600 mg Vial Label

PRINCIPAL DISPLAY PANEL

NDC 0069-0112-01

1 Vial

Rifampin for
Injection, USP
600 mg/vial

Sterile

For IV Infusion Only

Rx only

Pfizer Injectables

Principal Display Panel - 600 mg Vial Carton